Compounds > alendronate

alendronate and mannitol

alendronate has been researched along with mannitol in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alferiev, IS; Amidon, GL; Breuer, E; Cohen, H; El Hanany-Rozen, N; Ezra, A; Gati, I; Golomb, G; Hoffman, A; Mönkkönen, J; Stepensky, D; Törmälehto, S; Weiss, G1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Alferiev, IS; Breuer, E; Cohen, H; Ezra, A; Golomb, G; Hägele, G; Hoffman, A; Mönkkönen, J; Ornoy, A; Patlas, N; Pinto, T; Sagi, H; Seibel, MJ; Solomon, V; Stepensky, D1
Ezzati Nazhad Dolatabadi, J; Hamishehkar, H; Valizadeh, H1

Reviews

1 review(s) available for alendronate and mannitol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for alendronate and mannitol

ArticleYear
A peptide prodrug approach for improving bisphosphonate oral absorption.
    Journal of medicinal chemistry, 2000, Oct-05, Volume: 43, Issue:20

    Topics: Administration, Oral; Alendronate; Animals; Biological Availability; Caco-2 Cells; Carrier Proteins; Chemical Precipitation; Dipeptides; Diphosphonates; Durapatite; Humans; Injections, Intravenous; Intestinal Absorption; Pamidronate; Peptide Transporter 1; Prodrugs; Rats; Symporters; Tissue Distribution

2000
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate.
    Pharmaceutical research, 1999, Volume: 16, Issue:9

    Topics: Administration, Oral; Alendronate; Animals; Antineoplastic Agents; Betaine; Bone Diseases; Bone Neoplasms; Calcium; Capsules; Carcinoma 256, Walker; Cell Line; Diphosphonates; Diuretics, Osmotic; Durapatite; Injections, Intravenous; Intestinal Absorption; Macrophages; Male; Mannitol; Osteogenesis; Pamidronate; Rats; Rats, Inbred Strains; Tight Junctions; Tissue Distribution

1999
Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance.
    Drug development and industrial pharmacy, 2015, Volume: 41, Issue:9

    Topics: Administration, Inhalation; Aerosols; Alendronate; Bone Density Conservation Agents; Chemistry, Pharmaceutical; Drug Compounding; Drug Delivery Systems; Dry Powder Inhalers; Lipids; Mannitol; Microscopy, Electron, Scanning; Nanoparticles

2015